CannaPharmaRX, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Calgary, ab / accesswire / april 2, 2024 / cannapharmarx, inc. (otc pink:cpmd), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has extinguished convertible notes on the company. this transaction will avoid potential dilution of the company's stock and protect shareholder interests.

Cannapharmarx products have been approved for sale in multiple countries worldwide calgary, ab / accesswire / march 14, 2024 / cannapharmarx, inc. (otc pink:cpmd), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has received its first purchase order covering the output for the first four harvests. this product was shipped on march 11 to a canadian lp for distribution within canada.

Calgary, ab / accesswire / march 12, 2024 / cannapharmarx, inc. (otc pink:cpmd), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has completed its first five grows and harvests that are ready for sale. samples of the newer grows have been sent to an independent certified lab for testing, as required.

Calgary, ab / accesswire / march 7, 2024 / cannapharmarx, inc. (otc pink:cpmd), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it will hold an investor conference call on tuesday, march19, 2024 at 2pm eastern time to give an update on the year to date progress of cannapharmarx inc. chief executive officer dean medwid will be presenting with the topics being discussed will include: review of 2023 operational activities licensing update product update supply partner(s) update forecasted revenues interested parties can join the conference call by dialing in as directed below. north american toll free: 1-530-881-1212 passcode: 1674609 pin: 615253385# passcode: 1674609 an archived replay of the webcast will be available at: https://investors...

Calgary, ab / accesswire / march 5, 2024 / cannapharmarx, inc. (otc pink:cpmd), a future leader in ultramodern, highly efficient cannabis production facilities announced today that the company finalized a supply agreement with ican green s.a. de c.v ("ican"), a division of ican investing group llc.

CALGARY, AB / ACCESSWIRE / March 7, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it will hold an investor conference call on Tuesday, March19, 2024 at 2PM Eastern time to give an update on the year to date progress of CannaPharmaRx Inc. Chief Executive Officer Dean Medwid will be presenting with the topics being discussed will include: Review of 2023 Operational Activities Licensing Update Product Update Supply Partner(s) Update Forecasted Revenues Interested parties can join the conference call by dialing in as directed below. North American Toll Free: 1-530-881-1212 Passcode: 1674609 PIN: 615253385# Passcode: 1674609 An archived replay of the webcast will be available at: https://investors...

CALGARY, AB / ACCESSWIRE / July 13, 2021 / CannapharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today the sale of its Hanover, Ontario facility for $2,000,000 CAD. The Hanover facility includes ten acres of land and 48,800 square feet of growing space.

CALGARY, AB / ACCESSWIRE / June 24, 2021 / CannaPharmaRx, Inc. (OTC PINK:CPMD) a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced that it has been brought to its attention that a Third Party has issued a Press Release. Management believes this update is from an unaffiliated third party posting information about the company.

Agreement Provides Exposure to Israeli Medicinal Cannabis Market CALGARY, AB / ACCESSWIRE / June 16, 2021 / CannapharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today it has formally executed an agreement with K&K Consulting to broaden its exposure to the medical cannabis market in Israel. Based upon current analyses, the cannabis patient numbers in Israel have reached a record high in 2020, with over 60,000 users.

CALGARY, AB / ACCESSWIRE / March 25, 2021 / CannapharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today that it has consolidated its Board of Directors to include a team more suitable for the recently announced asset and facility offer acceptance in Saskatchewan and Alberta. Effective March 12, 2021, CannapharmaRX has accepted the resignations from Jim Samuelson and Matt Nicosia, both of whom will focus on other business obligations.

CALGARY, AB / ACCESSWIRE / January 19, 2021 / CannapharmaRx, Inc. (OTC PINK:CPMD) a future leader in ultramodern, highly efficient cannabis production facilities in Canada announced today that it has secured a commitment letter for twelve million dollars ($12,000,000) for the recently announced purchase of the cannabis cultivation and production business located at, and operated out of Cremona, Alberta and other acquisitions of cannabis cultivation and production facilities. The loan, which is fully collateralized by the facilities, will provide CannapharmaRx with the capital to complete the purchase of the 55,200 square foot facility, which is capable of producing 5,200 kilograms of cannabis biomass per year.

CALGARY, AB / ACCESSWIRE / January 12, 2021 / CannapharmaRx, Inc. (OTC PINK:CPMD) a future leader in ultramodern, highly efficient cannabis production facilities in Canada announced today that it has entered into a definitive agreement to purchase certain assets including the title to related fee simple lands and facility required for the cannabis cultivation and production business, located at and operated out of Cremona, Alberta. The transaction, subject to certain closing conditions, is scheduled to close in February 2021.